1-12 of 12
J. Sanchez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Durable MRD and Imaging-Negative Remission ≥ 5 Years Post-Therapy Predicts Long-Term Progression-Free Survival in Multiple Myeloma Patients - a Single-Center Observational Study

Lucia Y Chen, Santiago Thibaud, Ajai Chari, Joshua Richter, Hearn Jay Cho, Larysa J Sanchez, Cesar Rodriguez, Adriana C Rossi, Shambavi Richard, Samir Parekh, Sundar Jagannath
Journal: Blood
Blood (2023) 142 (Supplement 1): 1998.
https://doi.org/10.1182/blood-2023-190368
Published: 2023
Journal Articles

Outcomes after CAR T Cells in Multiple Myeloma Patients with Extramedullary and Paramedullary Disease

Darren Pan, Tarek H. Mouhieddine, Weijia Fu, Erin Moshier, Samir Parekh, Sundar Jagannath, Adriana C Rossi, Joshua Richter, Cesar Rodriguez, Larysa J Sanchez, Santiago Thibaud, Hearn Jay Cho, Shambavi Richard
Journal: Blood
Blood (2023) 142 (Supplement 1): 1006.
https://doi.org/10.1182/blood-2023-177749
Published: 2023
Journal Articles

Inflammatory Marker Levels, Age, Race and Prior Treatment Burden Independently Predict Delayed Hematologic Recovery after BCMA-Directed CART Therapy in Multiple Myeloma

Santiago Thibaud, Jerrel Catlett, Saoirse Bodnar, MD Babu Mia, Ajai Chari, Joshua Richter, Hearn Jay Cho, Larysa J Sanchez, Cesar Rodriguez, Adriana C Rossi, Sundar Jagannath, Shambavi Richard, Samir Parekh
Journal: Blood
Blood (2023) 142 (Supplement 1): 2002.
https://doi.org/10.1182/blood-2023-190772
Published: 2023
Journal Articles

Inflammatory Biomarkers and Outcomes in Multiple Myeloma Patients after CAR T-Cell Therapy

Darren Denjay Pan, Tarek H. Mouhieddine, Weijia Fu, Erin Moshier, Samir Parekh, Sundar Jagannath, Adriana C Rossi, Hearn Jay Cho, Joshua Richter, Larysa J Sanchez, Santiago Thibaud, Cesar Rodriguez, Shambavi Richard
Journal: Blood
Blood (2023) 142 (Supplement 1): 92.
https://doi.org/10.1182/blood-2023-188310
Published: 2023
Journal Articles

Confirmed Pathogenic Germline Variants in Cancer Predisposition Genes Incidentally Detected in Somatic Genomic Profiling of Multiple Myeloma Patients

Santiago Thibaud, William Genthe, Saoirse Bodnar, Alessandro Lagana, Jane Houldsworth, Ajai Chari, Adriana C Rossi, Cesar Rodriguez, Larysa J Sanchez, Shambavi Richard, Joshua Richter, Kenan Onel, Sundar Jagannath, Tehilla Brander, Samir Parekh
Journal: Blood
Blood (2023) 142 (Supplement 1): 534.
https://doi.org/10.1182/blood-2023-190878
Published: 2023
Journal Articles

Efficacy and Safety of Ruxolitinib and Steroids for Treating Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

James R. Berenson, MD, Noemi Silagan, MD, Jennifer To, BS, Tanya M. Spektor, PhD, Daisy Martinez, Armando J. Sanchez, Eli Forouzan, Regina Swift, Benjamin Eades, PharmD, Gary Schwartz, MD, Shahrooz Eshaghian, MD, Ralph V. Boccia, MD, Honghao Hank Yang, Stephen Lim, MD, Robert Vescio, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 36.
https://doi.org/10.1182/blood-2020-143005
Published: 2020
Journal Articles

A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)

James R. Berenson, MD, Jennifer To, BS, Tanya M. Spektor, PhD, Daisy Martinez, Armando J. Sanchez, MBA, Carley Turner, CCRP, Regina Swift, Benjamin Eades, PharmD, Gary Schwartz, MD, Shahrooz Eshaghian, MD, Laura V. Stampleman, Robert A. Moss, MD, Youram Nassir, MD, Ravindranath Patel, MD, Alberto Bessudo, MD, Daniel Greenwald, MD, Ralph V. Boccia, MD, Stephen Lim, MD, Robert Vescio, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1903.
https://doi.org/10.1182/blood-2019-131370
Published: 2019
Journal Articles

Homozygous Antithrombin Deficient Type II (99Leu to Phe mutation): Description of a Successful Outcome during Pregnancy

C. Muñoz Novas, C. Pascual, J. Sanchez, A. Rodriguez, G. Pérez, M. Kwon, A. Gomez-Pineda, J. Corral, J. Diez-Martín
Journal: Blood
Blood (2008) 112 (11): 4104.
https://doi.org/10.1182/blood.V112.11.4104.4104
Published: 2008
Journal Articles

The flatiron mutation in mouse ferroportin acts as a dominant negative to cause ferroportin disease

Irene E. Zohn, Ivana De Domenico, Andrew Pollock, Diane McVey Ward, Jessica F. Goodman, Xiayun Liang, Amaru J. Sanchez, Lee Niswander, Jerry Kaplan
Journal: Blood
Blood (2007) 109 (10): 4174–4180.
https://doi.org/10.1182/blood-2007-01-066068
Published: 2007
Journal Articles

Treatment of Diffuse Large B Cell Lymphoma with CHOP and Rituximab. Results of a Multicenter Study with 236 Patients.

Javier De la Serna, R. Ayala, M. Canales, P. Giraldo, M. de la Cruz-Mora, A. Rueda, C. Montalban, J. Queizan, J. Garcia-Vela, F. Feliu, C. Calle, B. Hernandez, R. Hernandez, F. Solano, J. Peñalver, J. Ojanguren, J. Sanchez-Guilarte, C. Morante, C. Nicolas, A. Roman, L. Palomera, J. Diaz-Mediavilla
Journal: Blood
Blood (2005) 106 (11): 4736.
https://doi.org/10.1182/blood.V106.11.4736.4736
Published: 2005
Journal Articles

Activation of the P38 MAPK Pathway Mediates Resistance to Ara-C y Bcr/Abl Positive Cells.

Victor J. Sanchez, MD, Clara I. Aceves, MD, Juan C. Gomez, MD, Felix Manso, MD, Juan R. Romero, MD, Junia V. Melo, MD, Ricardo Sanchez-Prieto, MD
Journal: Blood
Blood (2005) 106 (11): 1528.
https://doi.org/10.1182/blood.V106.11.1528.1528
Published: 2005
Journal Articles

Subcellular distribution and characterization of acetylcholinesterase activities from sheep platelets: relationships between temperature- dependence and environment

J Sanchez-Yague, JA Cabezas, M Llanillo
Journal: Blood
Blood (1990) 76 (4): 737–744.
https://doi.org/10.1182/blood.V76.4.737.737
Published: 1990